Pershing Edward reported PVCT

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001493152-26-048321

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 23, 2026

Published

Oct 23, 2026

Ingested by INSIDER

Nov 5, 02:09 UTC

Last re-read

Nov 5, 02:09 UTC

Extracted facts

Filer

Pershing Edward

Role

Director, CEO, 10% Owner

Transaction

Option exerciseAs filed: “M”

Asset

PROVECTUS BIOPHARMACEUTICALS, INC. — 8% Unsecured Convertible Promissory Note

Ticker

PVCT

Price per share

$0

Execution date (reported)

Oct 23, 2026

Days from execution to publication

0

What this establishes

Pershing Edward filed this Form 4 reporting a option exercise of PVCT on Oct 23, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, CEO, 10% Owner

Pershing Edwardcik:0001689739

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.cik:0000315545

Revision history · 0

No field has changed since this record was first ingested.